A Prospective Study evaluating Safety and influence of tofacitinib on reactivation of HBV infection in HBsAg carriers with Ankylosing Spondylitis
Latest Information Update: 30 Jun 2020
At a glance
- Drugs Tofacitinib (Primary) ; Entecavir
- Indications Ankylosing spondylitis; Hepatitis B
- Focus Adverse reactions; Pharmacodynamics
Most Recent Events
- 30 Jun 2020 New trial record
- 06 Jun 2020 Results presented at the 21st Annual Congress of the European League Against Rheumatism